Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002750 · ClinicalTrials.gov registry record · Phase 1
Melphalan in Patients With Neoplastic Meningitis
A Phase 1 study, sponsored by Duke University.
- Completed
- Registry status
- Phase 1
- Development phase
- 6
- Enrollment target
NCT00002750 is a Phase 1 study that has completed, run by Duke University. The registered enrollment target is 6 participants.
The verdict
NCT00002750, a Phase 1 study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 6 participants
- Enrollment target
Study Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase I trial to study the effectiveness of melphalan in patients with persistent or recurrent neoplastic meningitis.
Interventions
- DRUG melphalan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 1992-12 |
| Est. Completion | 2001-05 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00002750
The ClinicalTrials.gov registry entry for NCT00002750 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which melphalan is the first listed.
NCT00002750 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00002750 about?
NCT00002750 is a clinical study titled "Melphalan in Patients With Neoplastic Meningitis". RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase I trial to study the effectiveness of melphalan in patients with persistent or recurrent neoplastic meningitis.
What is the current status of trial NCT00002750?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 6 participants. The study started on 1992-12. Estimated completion is 2001-05.
What interventions are being tested in trial NCT00002750?
The interventions under investigation include: melphalan (DRUG).
Who is sponsoring clinical trial NCT00002750?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.